Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):36–44. doi: 10.1136/hrt.76.3_suppl_3.36

The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides

A Mark Richards 1
PMCID: PMC484487  PMID: 8983665

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abell T. J., Richards A. M., Ikram H., Espiner E. A., Yandle T. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun. 1989 May 15;160(3):1392–1396. doi: 10.1016/s0006-291x(89)80158-5. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. V., Millar N. D., O'Hare J. P., Mackenzie J. C., Corrall R. J., Bloom S. R. Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man. Clin Sci (Lond) 1986 Sep;71(3):319–322. doi: 10.1042/cs0710319. [DOI] [PubMed] [Google Scholar]
  3. Berk B. C., Vekshtein V., Gordon H. M., Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989 Apr;13(4):305–314. doi: 10.1161/01.hyp.13.4.305. [DOI] [PubMed] [Google Scholar]
  4. Cao L., Gardner D. G. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension. 1995 Feb;25(2):227–234. doi: 10.1161/01.hyp.25.2.227. [DOI] [PubMed] [Google Scholar]
  5. Cargill R. I., Struthers A. D., Lipworth B. J. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Clin Sci (Lond) 1995 Jan;88(1):81–86. doi: 10.1042/cs0880081. [DOI] [PubMed] [Google Scholar]
  6. Charles C. J., Richards A. M., Espiner E. A. Central C-type natriuretic peptide but not atrial natriuretic factor lowers blood pressure and adrenocortical secretion in normal conscious sheep. Endocrinology. 1992 Oct;131(4):1721–1726. doi: 10.1210/endo.131.4.1396317. [DOI] [PubMed] [Google Scholar]
  7. Cheung B. M., Brown M. J. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J Hypertens. 1994 Apr;12(4):449–454. [PubMed] [Google Scholar]
  8. Clinkingbeard C., Sessions C., Shenker Y. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism. J Clin Endocrinol Metab. 1990 Mar;70(3):582–589. doi: 10.1210/jcem-70-3-582. [DOI] [PubMed] [Google Scholar]
  9. Crozier I., Richards A. M., Foy S. G., Ikram H. Electrophysiological effects of atrial natriuretic peptide on the cardiac conduction system in man. Pacing Clin Electrophysiol. 1993 Apr;16(4 Pt 1):738–742. doi: 10.1111/j.1540-8159.1993.tb01653.x. [DOI] [PubMed] [Google Scholar]
  10. Cuneo R. C., Espiner E. A., Nicholls M. G., Yandle T. G., Livesey J. H. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J Clin Endocrinol Metab. 1987 Oct;65(4):765–772. doi: 10.1210/jcem-65-4-765. [DOI] [PubMed] [Google Scholar]
  11. Elsner D., Müntze A., Kromer E. P., Riegger G. A. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. Am J Cardiol. 1992 Aug 15;70(4):494–498. doi: 10.1016/0002-9149(92)91196-b. [DOI] [PubMed] [Google Scholar]
  12. Espiner E. A. Physiology of natriuretic peptides. J Intern Med. 1994 Jun;235(6):527–541. doi: 10.1111/j.1365-2796.1994.tb01261.x. [DOI] [PubMed] [Google Scholar]
  13. Favrat B., Burnier M., Nussberger J., Lecomte J. M., Brouard R., Waeber B., Brunner H. R. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension. J Hypertens. 1995 Jul;13(7):797–804. [PubMed] [Google Scholar]
  14. Furuya M., Yoshida M., Hayashi Y., Ohnuma N., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991 Jun 28;177(3):927–931. doi: 10.1016/0006-291x(91)90627-j. [DOI] [PubMed] [Google Scholar]
  15. Garcia N. H., Garvin J. L. ANF and angiotensin II interact via kinases in the proximal straight tubule. Am J Physiol. 1995 Apr;268(4 Pt 2):F730–F735. doi: 10.1152/ajprenal.1995.268.4.F730. [DOI] [PubMed] [Google Scholar]
  16. Gavras H., Kremer D., Brown J. J., Gray B., Lever A. F., MacAdam R. F., medina A., Morton J. J., Robertson J. I. Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J. 1975 Mar;89(3):321–332. doi: 10.1016/0002-8703(75)90082-4. [DOI] [PubMed] [Google Scholar]
  17. Gros C., Noël N., Souque A., Schwartz J. C., Danvy D., Plaquevent J. C., Duhamel L., Duhamel P., Lecomte J. M., Bralet J. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4210–4214. doi: 10.1073/pnas.88.10.4210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harris P. J., Thomas D., Morgan T. O. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature. 1987 Apr 16;326(6114):697–698. doi: 10.1038/326697a0. [DOI] [PubMed] [Google Scholar]
  19. Holmes S. J., Espiner E. A., Richards A. M., Yandle T. G., Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993 Jan;76(1):91–96. doi: 10.1210/jcem.76.1.8380606. [DOI] [PubMed] [Google Scholar]
  20. Hunt P. J., Richards A. M., Espiner E. A., Nicholls M. G., Yandle T. G. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab. 1994 Jun;78(6):1428–1435. doi: 10.1210/jcem.78.6.8200946. [DOI] [PubMed] [Google Scholar]
  21. Itoh H., Nakao K., Yamada T., Morii N., Shiono S., Sugawara A., Saito Y., Mukoyama M., Arai H., Imura H. Brain renin-angiotensin. Central control of secretion of atrial natriuretic factor from the heart. Hypertension. 1988 Feb;11(2 Pt 2):I57–I61. doi: 10.1161/01.hyp.11.2_pt_2.i57. [DOI] [PubMed] [Google Scholar]
  22. Itoh H., Pratt R. E., Dzau V. J. Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth. Biochem Biophys Res Commun. 1991 May 15;176(3):1601–1609. doi: 10.1016/0006-291x(91)90471-i. [DOI] [PubMed] [Google Scholar]
  23. Janssen W. M., de Zeeuw D., van der Hem G. K., de Jong P. E. Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension. 1989 Jun;13(6 Pt 1):640–646. doi: 10.1161/01.hyp.13.6.640. [DOI] [PubMed] [Google Scholar]
  24. Katsube N., Schwartz D., Needleman P. Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem Biophys Res Commun. 1985 Dec 31;133(3):937–944. doi: 10.1016/0006-291x(85)91226-4. [DOI] [PubMed] [Google Scholar]
  25. Kawaguchi H., Sawa H., Yasuda H. Effect of atrial natriuretic factor on angiotensin converting enzyme. J Hypertens. 1990 Aug;8(8):749–753. doi: 10.1097/00004872-199008000-00009. [DOI] [PubMed] [Google Scholar]
  26. Kenny A. J., Bourne A., Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J. 1993 Apr 1;291(Pt 1):83–88. doi: 10.1042/bj2910083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Koller K. J., Lowe D. G., Bennett G. L., Minamino N., Kangawa K., Matsuo H., Goeddel D. V. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991 Apr 5;252(5002):120–123. doi: 10.1126/science.1672777. [DOI] [PubMed] [Google Scholar]
  28. Lazzeri C., Franchi F., Porciani C., Fronzaroli C., Casini Raggi V., De Feo M. L., Mannelli M., Cersosimo R. M., La Villa G. Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. Am J Hypertens. 1995 Aug;8(8):799–807. doi: 10.1016/0895-7061(95)00147-h. [DOI] [PubMed] [Google Scholar]
  29. Lee M. E., Miller W. L., Edwards B. S., Burnett J. C., Jr Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest. 1989 Dec;84(6):1962–1966. doi: 10.1172/JCI114385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Linz W., Schölkens B. A., Albus U., Petry P., Breipohl G., Knolle J. Atrial natriuretic factor protects the isolated working ischaemic rat heart against the action of angiotensin II. J Hypertens Suppl. 1988 Dec;6(4):S339–S341. doi: 10.1097/00004872-198812040-00105. [DOI] [PubMed] [Google Scholar]
  31. Luparini R. L., Ferri C., Santucci A., Balsano F. Atrial natriuretic peptide in non-modulating essential hypertension. Hypertension. 1993 Jun;21(6 Pt 1):803–809. doi: 10.1161/01.hyp.21.6.803. [DOI] [PubMed] [Google Scholar]
  32. Maack T., Suzuki M., Almeida F. A., Nussenzveig D., Scarborough R. M., McEnroe G. A., Lewicki J. A. Physiological role of silent receptors of atrial natriuretic factor. Science. 1987 Oct 30;238(4827):675–678. doi: 10.1126/science.2823385. [DOI] [PubMed] [Google Scholar]
  33. Marin-Grez M., Fleming J. T., Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature. 1986 Dec 4;324(6096):473–476. doi: 10.1038/324473a0. [DOI] [PubMed] [Google Scholar]
  34. Matsubara H., Umeda Y., Yamane Y., Nishikawa M., Taniguchi T., Inada M. Role of atrial natriuretic polypeptides for exaggerated natriuresis in essential hypertension. Am J Cardiol. 1987 Sep 15;60(8):708–714. doi: 10.1016/0002-9149(87)90387-0. [DOI] [PubMed] [Google Scholar]
  35. Morishita Y., Sano T., Ando K., Saitoh Y., Kase H., Yamada K., Matsuda Y. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun. 1991 May 15;176(3):949–957. doi: 10.1016/0006-291x(91)90374-g. [DOI] [PubMed] [Google Scholar]
  36. Münzel T., Kurz S., Holtz J., Busse R., Steinhauer H., Just H., Drexler H. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation. 1992 Oct;86(4):1089–1098. doi: 10.1161/01.cir.86.4.1089. [DOI] [PubMed] [Google Scholar]
  37. Nicholls M. G. The natriuretic peptides in heart failure. J Intern Med. 1994 Jun;235(6):515–526. doi: 10.1111/j.1365-2796.1994.tb01260.x. [DOI] [PubMed] [Google Scholar]
  38. Northridge D. B., Jardine A. G., Alabaster C. T., Barclay P. L., Connell J. M., Dargie H. J., Dilly S. G., Findlay I. N., Lever A. F., Samuels G. M. Effects of UK 69 578: a novel atriopeptidase inhibitor. Lancet. 1989 Sep 9;2(8663):591–593. doi: 10.1016/s0140-6736(89)90714-9. [DOI] [PubMed] [Google Scholar]
  39. Oikawa S., Imai M., Ueno A., Tanaka S., Noguchi T., Nakazato H., Kangawa K., Fukuda A., Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide. Nature. 1984 Jun 21;309(5970):724–726. doi: 10.1038/309724a0. [DOI] [PubMed] [Google Scholar]
  40. Pham I., Gonzalez W., el Amrani A. I., Fournié-Zaluski M. C., Philippe M., Laboulandine I., Roques B. P., Michel J. B. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol Exp Ther. 1993 Jun;265(3):1339–1347. [PubMed] [Google Scholar]
  41. Rabelink T. J., Koomans H. A., van de Stolpe A., Bijlsma J. A., Dorhout Mees E. J. Effects of atrial natriuretic peptide on distal tubule function in humans. Kidney Int. 1990 Mar;37(3):996–1001. doi: 10.1038/ki.1990.76. [DOI] [PubMed] [Google Scholar]
  42. Richards A. M., Crozier I. G., Holmes S. J., Espiner E. A., Yandle T. G., Frampton C. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens. 1993 Feb;11(2):163–170. doi: 10.1097/00004872-199302000-00008. [DOI] [PubMed] [Google Scholar]
  43. Richards A. M., Crozier I. G., Kosoglou T., Rallings M., Espiner E. A., Nicholls M. G., Yandle T. G., Ikram H., Frampton C. Endopeptidase 24.11 inhibition by SCH 42495 in essential hypertension. Hypertension. 1993 Jul;22(1):119–126. doi: 10.1161/01.hyp.22.1.119. [DOI] [PubMed] [Google Scholar]
  44. Richards A. M., Espiner E. A., Ikram H., Yandle T. G. Atrial natriuretic factor in hypertension: bioactivity at normal plasma levels. Hypertension. 1989 Sep;14(3):261–268. doi: 10.1161/01.hyp.14.3.261. [DOI] [PubMed] [Google Scholar]
  45. Richards A. M., McDonald D., Fitzpatrick M. A., Nicholls M. G., Espiner E. A., Ikram H., Jans S., Grant S., Yandle T. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab. 1988 Dec;67(6):1134–1139. doi: 10.1210/jcem-67-6-1134. [DOI] [PubMed] [Google Scholar]
  46. Richards A. M., Nicholls M. G., Ikram H., Webster M. W., Yandle T. G., Espiner E. A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. doi: 10.1016/s0140-6736(85)91207-3. [DOI] [PubMed] [Google Scholar]
  47. Richards A. M., Rao G., Espiner E. A., Yandle T. Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor. Hypertension. 1989 Mar;13(3):193–199. doi: 10.1161/01.hyp.13.3.193. [DOI] [PubMed] [Google Scholar]
  48. Richards A. M. The natriuretic peptides and hypertension. J Intern Med. 1994 Jun;235(6):543–560. doi: 10.1111/j.1365-2796.1994.tb01262.x. [DOI] [PubMed] [Google Scholar]
  49. Richards A. M., Tonolo G., Tree M., Robertson J. I., Montorsi P., Leckie B. J., Polonia J. Atrial natriuretic peptides and renin release. Am J Med. 1988 Mar 11;84(3A):112–118. doi: 10.1016/0002-9343(88)90214-8. [DOI] [PubMed] [Google Scholar]
  50. Richards A. M., Tree M., Tonolo G., Montorsi P., Polonia J., Morton J. J., Fraser R., Frampton C. Atrial natriuretic factor and changes in the aldosterone response to angiotensin II in sodium depleted dogs. Clin Exp Hypertens. 1993 Mar;15(2):379–394. doi: 10.3109/10641969309032941. [DOI] [PubMed] [Google Scholar]
  51. Richards A. M., Wittert G. A., Crozier I. G., Espiner E. A., Yandle T. G., Ikram H., Frampton C. Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II. J Hypertens. 1993 Apr;11(4):407–416. doi: 10.1097/00004872-199304000-00011. [DOI] [PubMed] [Google Scholar]
  52. Richards A. M., Wittert G. A., Espiner E. A., Yandle T. G., Ikram H., Frampton C. Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers. Circ Res. 1992 Dec;71(6):1501–1507. doi: 10.1161/01.res.71.6.1501. [DOI] [PubMed] [Google Scholar]
  53. Richards M., Espiner E., Frampton C., Ikram H., Yandle T., Sopwith M., Cussans N. Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects. Hypertension. 1990 Sep;16(3):269–276. doi: 10.1161/01.hyp.16.3.269. [DOI] [PubMed] [Google Scholar]
  54. Rudd M. A., Plavin S., Hirsch A. T., Ingelfinger J. R., Dzau V. J. Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation. Circ Res. 1989 Nov;65(5):1324–1329. doi: 10.1161/01.res.65.5.1324. [DOI] [PubMed] [Google Scholar]
  55. Sagnella G. A., Markandu N. D., Shore A. C., MacGregor G. A. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet. 1985 Nov 30;2(8466):1208–1211. doi: 10.1016/s0140-6736(85)90741-x. [DOI] [PubMed] [Google Scholar]
  56. Sano T., Morishita Y., Matsuda Y., Yamada K. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats. J Pharmacol Exp Ther. 1992 Feb;260(2):825–831. [PubMed] [Google Scholar]
  57. Seymour A. A., Asaad M. M., Lanoce V. M., Langenbacher K. M., Fennell S. A., Rogers W. L. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. J Pharmacol Exp Ther. 1993 Aug;266(2):872–883. [PubMed] [Google Scholar]
  58. Shenker Y., Bates E. R., Egan B. H., Hammoud J., Grekin R. J. Effect of vasopressors on atrial natriuretic factor and hemodynamic function in humans. Hypertension. 1988 Jul;12(1):20–25. doi: 10.1161/01.hyp.12.1.20. [DOI] [PubMed] [Google Scholar]
  59. Stasch J. P., Hirth C., Kazda S., Neuser D. The reduction of renin and aldosterone as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides. Life Sci. 1988;42(5):511–516. doi: 10.1016/0024-3205(88)90091-4. [DOI] [PubMed] [Google Scholar]
  60. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988 Mar 3;332(6159):78–81. doi: 10.1038/332078a0. [DOI] [PubMed] [Google Scholar]
  61. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990 Apr 30;168(2):863–870. doi: 10.1016/0006-291x(90)92401-k. [DOI] [PubMed] [Google Scholar]
  62. Tang J., Webber R. J., Chang D., Chang J. K., Kiang J., Wei E. T. Depressor and natriuretic activities of several atrial peptides. Regul Pept. 1984 Sep;9(1-2):53–59. doi: 10.1016/0167-0115(84)90007-7. [DOI] [PubMed] [Google Scholar]
  63. Tonolo G., Richards A. M., Manunta P., Troffa C., Pazzola A., Madeddu P., Towrie A., Fraser R., Glorioso N. Low-dose infusion of atrial natriuretic factor in mild essential hypertension. Circulation. 1989 Oct;80(4):893–902. doi: 10.1161/01.cir.80.4.893. [DOI] [PubMed] [Google Scholar]
  64. Tuchelt H., Eschenhagen G., Bähr V., Schwietzer G., Thiede H. M., Oelkers W. Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man. Clin Sci (Lond) 1990 Jul;79(1):57–65. doi: 10.1042/cs0790057. [DOI] [PubMed] [Google Scholar]
  65. Volpe M., Atlas S. A., Sosa R. E., Marion D. E., Mueller F. B., Sealey J. E., Laragh J. H. Angiotensin II-induced atrial natriuretic factor release in dogs is not related to hemodynamic responses. Circ Res. 1990 Sep;67(3):774–779. doi: 10.1161/01.res.67.3.774. [DOI] [PubMed] [Google Scholar]
  66. Wada A., Tsutamoto T., Matsuda Y., Kinoshita M. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation. 1994 May;89(5):2232–2240. doi: 10.1161/01.cir.89.5.2232. [DOI] [PubMed] [Google Scholar]
  67. Wegner M., Stasch J. P., Hirth-Dietrich C., Dressel J., Voges K. P., Kazda S. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs. Clin Exp Hypertens. 1995 Aug;17(6):861–876. doi: 10.3109/10641969509033640. [DOI] [PubMed] [Google Scholar]
  68. Weidmann P., Gnädinger M. P., Ziswiler H. R., Shaw S., Bachmann C., Rascher W., Uehlinger D. E., Hasler L., Reubi F. C. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens Suppl. 1986 Jun;4(2):S71–S83. [PubMed] [Google Scholar]
  69. Williams G. H., Moore T. J., Hollenberg N. K. Renal abnormalities in nonmodulating essential hypertension. Am J Kidney Dis. 1987 Jul;10(1 Suppl 1):39–44. [PubMed] [Google Scholar]
  70. Yandle T. G. Biochemistry of natriuretic peptides. J Intern Med. 1994 Jun;235(6):561–576. doi: 10.1111/j.1365-2796.1994.tb01263.x. [DOI] [PubMed] [Google Scholar]
  71. Yoshimura M., Yasue H., Morita E., Sakaino N., Jougasaki M., Kurose M., Mukoyama M., Saito Y., Nakao K., Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991 Oct;84(4):1581–1588. doi: 10.1161/01.cir.84.4.1581. [DOI] [PubMed] [Google Scholar]
  72. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]
  73. de Zeeuw D., Janssen W. M., de Jong P. E. Atrial natriuretic factor: its (patho)physiological significance in humans. Kidney Int. 1992 May;41(5):1115–1133. doi: 10.1038/ki.1992.172. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES